GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.

Oncologic Drugs Advisory Committee (ODAC) has voted against the benefit/risk profile of GSK’s Blenrep (belantamab mafodotin) just days before the drug’s Prescription Drug User Fee Act (PDUFA) date.

In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...

The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.

The UK's FTSE 100 extended its winning streak to a fourth week on Friday, as investors looked past economic concerns to focus ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

An Omnicom spokesperson confirmed that the 2025 MM+M Agency 100 honoree will soon be folded into Omnicom Health subsidiaries.

The anemia treatment missed its main goal in a myelofibrosis study. Meanwhile, Blenrep's return to the U.S. market may have ...

Imperial is one of twelve research organisations selected to deliver the Government’s £54 million fund to recruit the world’s top researchers.

The provider of health, safety, hygiene and environmental consultancy and security solutions reported a pretax loss of GBP127,419 for the year to the end of March, swinging from a profit of GBP332,317 ...